{
    "2018-05-03": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Health Secretary Alex Azar: ‘Bold action is on the way’ for drug prices",
                "features": {
                    "keywords": [
                        "Health",
                        "Secretary",
                        "Alex",
                        "Azar",
                        "Bold",
                        "action",
                        "drug",
                        "prices"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-25",
                "original_text": "United Therapeutics (UTHR) Q1 Earnings Rise, Sales Drop Q/Q",
                "features": {
                    "keywords": [
                        "United",
                        "Therapeutics",
                        "UTHR",
                        "Q1",
                        "Earnings",
                        "Rise",
                        "Sales",
                        "Drop"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2018-05-03",
                "original_text": "Teva Stock Rises on Strong 1Q18 Results, Outlook Up",
                "features": {
                    "keywords": [
                        "Teva",
                        "Stock",
                        "Rises",
                        "Strong",
                        "1Q18",
                        "Results",
                        "Outlook",
                        "Up"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-15",
                "original_text": "Olumiant: A Key Drug in Rheumatoid Arthritis Indications",
                "features": {
                    "keywords": [
                        "Olumiant",
                        "Key",
                        "Drug",
                        "Rheumatoid",
                        "Arthritis",
                        "Indications"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-10",
                "original_text": "Label Expansion May Boost Trulicity’s Revenues",
                "features": {
                    "keywords": [
                        "Label",
                        "Expansion",
                        "Boost",
                        "Trulicity",
                        "Revenues"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-20",
                "original_text": "Factors that Could Drive Trulicity’s Revenue Growth in 2018",
                "features": {
                    "keywords": [
                        "Factors",
                        "Drive",
                        "Trulicity",
                        "Revenue",
                        "Growth",
                        "2018"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}